NVO

Novo Nordisk A S

5 catalysts on file

NVO

Novo Nordisk A S

Approval Confirmed

Wegovy HD

excess body weight

155d ago Mar 19, 2026

SEC 6-K verified 2mo ago

NVO

Novo Nordisk A S

Catalyst AI-extracted

Wegovy HD

excess body weight

142d ago Apr 1, 2026

SEC 6-K verified 2mo ago

NVO

Novo Nordisk A S

Phase 3 Confirmed

etavopivat

sickle cell disease

123d ago Apr 20, 2026

SEC 6-K verified 2mo ago

NVO

Novo Nordisk A S

Approval AI-extracted

etavopivat

sickle cell disease

T-minus 132 days ~ Dec 31, 2026

SEC 6-K verified 2mo ago

NVO

Novo Nordisk A/S

Phase 2 Estimated

UBT251

Overweight

T-minus 146 days Jan 14, 2027

ClinicalTrials.gov verified 2mo ago